Abu Dhabi scientists develop ‘smart molecules’ to detect and treat aggressive brain tumours
Researchers at New York University Abu Dhabi have developed innovative “smart molecules” capable of both detecting and treating brain tumours, marking a promising breakthrough in cancer research.
The study, published in the Journal of the American Chemical Society, focuses on Glioblastoma, one of the most aggressive and difficult-to-treat forms of brain cancer.
Dual-function breakthrough
The research addresses two major challenges in brain cancer care: accurately identifying tumours and delivering treatment directly to them.
According to the research team, the newly developed molecules remain inactive in healthy tissue but activate once they reach tumour sites, where the environment is slightly acidic. Upon activation, they release manganese ions that enhance visibility in MRI scans, allowing doctors to detect tumours with greater precision.
At the same time, the molecules trigger a therapeutic response that damages cancer cells, effectively combining diagnosis and treatment into a single approach.
Overcoming the blood-brain barrier
One of the most significant hurdles in treating brain tumours is the blood-brain barrier, which prevents many drugs from reaching the brain. Researchers confirmed that these smart molecules were able to cross this barrier and accumulate within glioblastoma tumours in laboratory and animal studies.
The molecules’ unique interlocked structure enables them to behave differently from traditional drugs, enhancing both targeting accuracy and therapeutic effectiveness.
Early-stage but promising
While the findings are still in early preclinical stages and not yet ready for clinical use, initial results have shown encouraging safety and imaging performance. Further testing, including human trials, will be required before the technology can be used in hospitals.
Boost to UAE’s research ambitions
The breakthrough highlights Abu Dhabi’s growing role in advanced medical research, supported by increased investment in life sciences and precision medicine.
Institutions such as the Department of Health Abu Dhabi, the Cleveland Clinic Abu Dhabi, and M42 continue to drive innovation in healthcare across the emirate.
Researchers say the development demonstrates the UAE’s potential to contribute to global scientific advancements, particularly in tackling complex diseases like brain cancer.
